MEDP vs NRC
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Sep 04, 2026
MEDP
NRC
Investment Advisor Scores
NRC
AI Analyst Insights
Detailed Metrics Comparison
| Metric | MEDP | NRC | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 30.1205 | 17.2117 | NRC |
| PEG Ratio | 2.7717 | 1.3234 | NRC |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 17.2% | 4.0% | MEDP |
| Earnings Growth | 37.1% | -44.0% | MEDP |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 47.0/100 | 49.1/100 | NRC |
| Profit Margin | 17.7% | 4.2% | MEDP |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | HOLD | HOLD | Tie |
Relative Price Performance (Last 90 Days)
Current Technical Phase
MEDP
MarkupPrice above SMA50, rising 50-day trend (10.5% over 20 days), RSI 51
NRC
MarkupPrice above SMA50, rising 50-day trend (4.0% over 20 days), RSI 53
Fundamentals Snapshot
| Metric | MEDP | NRC |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 30.6 | 20.5 |
| Trailing P/E | 34.9 | 81.7 |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.2% | 0.0% |
| Gross Margin | 0.7% | 0.6% |
| Operating Margin | 0.2% | 0.0% |
| EPS | 17.02 | 0.26 |
| Dividend Yield | — | 0.03% |